1. Stocks
    2. /
  2. Moderna (NASDAQ: MRNA)
    3. /

Moderna (NASDAQ: MRNA) Share Price and News

$36.85 $-2.92 (-7.3%) Saturday, 16 November 2024 at 8:00:00 am Australian Eastern Daylight Time

Moderna Chart and Price Data

About Moderna

Last updated 16-11-2024, 08:00:00am AEDT
Current Price $36.85
Change $-2.92 (-7.3%)
Close Price $36.85
Open Price $38.55
Bid $37.15
Ask $37.29
Day Range $35.80 - $38.70
Year Range $35.80 - $170.47
Volume 24,355,514
Average Volume 6,130,754
Market Cap $14,180,543,300.00
Earnings Per Share $-5.82

    • Moderna (NASDAQ: MRNA)
    Latest News

    Chalice Mining share price value and growth ASX shares
    Cheap Shares

    Macquarie (ASX:MQG) picks best ASX stocks to buy for 2021 post-COVID recovery

    | Brendon Lau

    News of another promising COVID‐19 vaccine pushed the market higher but the best stocks to buy for 2021 won’t be…

    Read more »

    Share Market News

    ASX 200 on watch after study shows Moderna's COVID-19 vaccine is 94.5% effective

    | James Mickleboro

    The ASX 200 will be on watch today after Moderna released even stronger phase 3 results for its COVID-19 vaccine...

    Read more »

    person receiving coronavirus vaccine injection into the arm
    International Stock News

    3 reasons Pfizer and BioNTech will have coronavirus vaccine data before Moderna

    | Brian Orelli, PhD

    Different clinical trial designs gives the duo an advantage, but coming in first isn't the end goal for vaccine makers.

    Read more »

    doctor giving little boy vaccine injection in his arm
    International Stock News

    Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial

    | Brian Orelli, PhD

    The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway.

    Read more »

    doctor making thumbs up gesture and holding vial labelled 'covid-19 vaccine' representing covid shares
    International Stock News

    The surefire vaccine winner following AstraZeneca's COVID-19 trial pause

    | Keith Speights

    Hint: It's not Moderna.

    Read more »

    International Stock News

    What if more than one company wins the coronavirus vaccine race?

    | Alex Carchidi

    The ability to globally distribute a vaccine is as important as the vaccine itself. To the best-equipped victors go the…

    Read more »

    CSL share price represented by hand in blue glove picks out a vial labelled 'covid-19 vaccine' from a row of vials
    International Stock News

    Coronavirus vaccine race: 7 key things you'll want to know

    | Keith Speights

    Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.

    Read more »

    Patient wearing mask gets COVID vaccine injection
    International Stock News

    AstraZeneca coronavirus vaccine clinical trial paused

    | Brian Orelli, PhD

    One participant fell ill, but the connection to treatment with AZD122 is unclear.

    Read more »

    International Stock News

    How to invest in coronavirus vaccine stocks

    | Keith Speights

    Just follow these three simple steps.

    Read more »

    Blue gloved hands holding up vials with covid vaccine labels
    International Stock News

    In the race for a coronavirus vaccine, can there be multiple winners?

    | Adria Cimino

    Demand says we may need several players crossing the finish line.

    Read more »

    International Stock News

    How Moderna went from coronavirus sequence to a phase-1-ready vaccine candidate in 42 Days

    | Brian Orelli, PhD

    Biotech company Moderna got a little help from Amazon's AWS in the race for a coronavirus vaccine.

    Read more »

    International Stock News

    Everything you need to know about the coronavirus vaccine race

    | Keith Speights

    Here are your answers to the questions that matter the most about COVID-19 vaccines in development

    Read more »

    Profile

    since

    Note